Prelude Therapeutics files $25M ATM equity offering via Jefferies

Prelude Therapeutics Inc

Filed prospectus supplement to sell up to $25M common stock under existing Sales Agreement with Jefferies LLC.
Offering supplements prior $75M capacity; shares sold from time to time at market prices.
Legal opinion from Morgan, Lewis & Bockius LLP filed as Exhibit 5.1.
Proceeds intended for general corporate purposes; no specific use disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.